Search
for
Sort by
Research 691–720 of 1000+
- IMPACT OF LOW DOSE FINASTERIDE FOR THE TREATMENT OF ANDROGENIC ALOPECIA ON SERUM PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN PARTICIPATED IN POPULATION-BASED SCREENING FOR PROSTATE CANCER
- Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?
- Serum prostate spesific antigen levels in women with androgenetic alopecia
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Risk factors for prostate cancer: a case-control study in Greece
- Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt
- Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Novel Anti-Prostate Cancer Curcumin Analogues That Enhance Androgen Receptor Degradation Activity
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Epidemiological study of prostate cancer (EPICAP): a population-based case–control study in France
- Endocrinology of the Aging Prostate: Current Concepts
- Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
- Ezetimibe Reduces Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Risk factors for prostate cancer: a case‐control study in Greece
- Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- The influence of <i>Castanea sativa</i> Mill. flower extract on hormonally and chemically induced prostate cancer in a rat model
- Effect of Saw Palmetto Supplements on Androgen-Sensitive LNCaP Human Prostate Cancer Cell Number and Syrian Hamster Flank Organ Growth
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia
- Terapia antiandrogénica como quimioprevención del cáncer de próstata
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells